NCT02008487

Brief Summary

This study will test a special powder for ulcers caused by a variety of conditions such as pressure that sometimes happen when a person is at the end of life. The powder will be applied to these ulcers to see if it helps with pain, odor and drainage (leakage). People who are being cared for by hospice or palliative care organizations will be invited to be in the study. The study will also find out if the powder is easy to use by caregivers as well as improving the comfort and quality of life of the person who has the ulcer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2013

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 11, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 6, 2016

Status Verified

April 1, 2016

Enrollment Period

2.7 years

First QC Date

December 6, 2013

Last Update Submit

April 4, 2016

Conditions

Keywords

woundpalliative carehospicepressure ulcers

Outcome Measures

Primary Outcomes (3)

  • adherence

    adherence to RGN107 protocol by licensed care providers and/or family or other caregivers providing wound care; measures include implementation of procedures, frequency of dressing changes.

    4 weeks

  • reach

    reach, enrollment, disenrollment, acceptability, satisfaction; measures include difficulties with recruitment and enrollment, side effects such as burning, peri-wound skin irritation.

    4 weeks

  • usability

    usability issues such as powder ability to stick to wound and ease of use of applying powder.

    4 weeks

Secondary Outcomes (2)

  • symptoms

    4 weeks

  • quality of life

    4 weeks

Study Arms (1)

Wound powder

OTHER

In both hospice settings, a registered nurse establishes the wound protocol per principles of wound care and agency guidelines. The cover dressing will be removed and the wound cleansed according to agency protocol (usual care) or as needed. The RGN107 powder, contained in a small squirt bottle, will be squeezed/sprinkled on the wound at each dressing change after cleansing or until a crust is formed. Once formed, the powder will be applied only minimally to reinforce crust integrity. The peri-wound skin will receive care and the cover dressing will be applied. Minimal manipulation of the crusted area will ensue once it has formed. Frequency of dressing changes depends on wound characteristics such as exudate.

Other: Wound powder application

Interventions

Powder application to wound per protocol.

Also known as: RGN107, MittiHeal
Wound powder

Eligibility Criteria

Age21 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 21 years or older
  • Patient prognosis \> 1 month and \< 6 months
  • Pressure wounds
  • Pain or odor or exudate score \> 2 on VAS
  • Wound caregiver able to perform required protocol activities

You may not qualify if:

  • Known allergies to Turmeric, Mint, Sandalwood
  • Using negative pressure wound therapy
  • Currently using topical creams or ointments applied to wound bed (powder will not adhere to these products)
  • Wound with eschar covering (powder will not stick)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Roper Hospice

Charleston, South Carolina, 29407, United States

Location

Hospice of Charleston

North Charleston, South Carolina, 29406, United States

Location

Odyssey Hospice

North Charleston, South Carolina, 29406, United States

Location

Related Links

MeSH Terms

Conditions

Pressure UlcerWounds and Injuries

Interventions

RGN107

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 6, 2013

First Posted

December 11, 2013

Study Start

April 1, 2013

Primary Completion

December 1, 2015

Study Completion

March 1, 2016

Last Updated

April 6, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will share

Data will be shared upon request and findings will be disseminated through publications and presentations.

Locations